Nanobiotix
Yahoo Finance • last year
NANOBIOTIX Announces the Availability of a Prospectus in Connection with Capital Increases Raising Total Gross Proceeds of Approximately $50M and the Exercise by the Underwriters of the Over-Allotment Option for an Additional Amount of Approximately $3.6M
Nanobiotix S.A. NBTXR3-RT + anti-PD-1 NBTXR3-RT + anti-PD-1: ongoing discussions at Nanobiotix relating to this potential study in recurrent and/or metastatic head and neck cancers under consultation prior to continuing discussions with t... Full story
Yahoo Finance • last year
Meta's Threads Hits 100M Users In Five Days, Foxconn Pulls Out From $19.5B Semiconductor India JV, Novo Nordisk's Weight-Loss Medications Under European Investigation Over Suicidal Risks: Today's Top Stories
Benzinga Meta's Threads Hits 100M Users In Just 5 Days, Becomes Fastest Growing App In History Meta Platforms Inc's (NASDAQ: META) Threads app has hit the milestone of 100 million users in the first five days of its launch, making it the... Full story
Yahoo Finance • last year
NANOBIOTIX Announces License Agreement for Worldwide Co-development and Commercialization of Potential First-In-Class Radioenhancer NBTXR3
Nanobiotix S.A. PARIS and CAMBRIDGE, Mass., July 10, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatme... Full story
Yahoo Finance • 2 years ago
NANOBIOTIX Provides First Quarter 2023 Operational and Financial Update
Nanobiotix S.A. Reported €30.2 million in cash and cash equivalents as of March 31, 2023 PARIS and CAMBRIDGE, Mass., May 17, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage bi... Full story
Yahoo Finance • 2 years ago
NANOBIOTIX to Provide Operational Update and Report Full Year 2022 Financial Results on April 24, 2023
Nanobiotix S.A. Conference Call and Webcast to be Held at 2:00 PM CEST/8:00 AM EDT on April 25, 2023 PARIS and CAMBRIDGE, Mass., April 17, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the “Company”), a late-stage... Full story
Yahoo Finance • 2 years ago
Nanobiotix to Provide Operational Update and Report Full Year 2022 Financial Results on March 28, 2023
Nanobiotix S.A. Conference Call and Webcast to be Held at 2:00 P.M CET/8:00 A.M. EDT on March 29, 2023 PARIS and CAMBRIDGE, Mass., March 14, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-s... Full story
Yahoo Finance • 3 years ago
NANOBIOTIX to Participate in Two Upcoming Investor Conferences
PARIS & CAMBRIDGE, Mass., May 11, 2022--(BUSINESS WIRE)--Regulatory News: NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the "Company"), a clinical-stage biotechnology company pioneering physics-based approaches to expand treatment possibi... Full story
Yahoo Finance • 3 years ago
Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulations of the Autorité des Marchés Financiers (French Financial Markets Authority) PARIS, May 10, 2022--(BUSINESS WIRE)--Regulatory News:... Full story
